- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/22 - Nitrogen and oxygen atoms
Patent holdings for IPC class C07D 237/22
Total number of patents in this class: 108
10-year publication summary
|
5
|
6
|
8
|
4
|
15
|
5
|
10
|
14
|
4
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| FMC Corporation | 848 |
7 |
| Takeda Pharmaceutical Company Limited | 2707 |
6 |
| Genentech, Inc. | 3976 |
4 |
| Janssen Pharmaceutica N.V. | 3407 |
4 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
4 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 635 |
4 |
| Novartis AG | 10882 |
3 |
| Boehringer Ingelheim International GmbH | 4705 |
3 |
| Aviara Pharmaceuticals, Inc. | 6 |
3 |
| Bristol-myers Squibb Company | 4872 |
2 |
| F. Hoffmann-La Roche AG | 7932 |
2 |
| Pfizer Inc. | 3371 |
2 |
| Allergan, Inc. | 2361 |
2 |
| Glaxosmithkline Intellectual Property Development Limited | 757 |
2 |
| Active Biotech AB | 60 |
2 |
| Arizona Board of Regents, a Body Corporate of The State of Arizona Acting for and on Behalf of Arizona State University | 290 |
2 |
| Astellas Pharma Inc. | 1088 |
2 |
| Biogen MA Inc. | 892 |
2 |
| Imago Biosciences, Inc. | 38 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 824 |
2 |
| Other owners | 48 |